Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,211 public trials 1,007 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung

NCT01561456

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +17 more
Locations
  • State Medical Institution: Republic Scientific Oncology Center Poselok, Minsk Oblast, Belarus
  • Gomel Regional Clinical Oncology Center Homyel, Belarus
  • Minsk City Clinical Oncology Center Minsk, Belarus
  • Vitebsk Regional Clinical Oncology Center Vitebsk, Belarus
View all 24 locations
View Trial Details
Completed

A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer

NCT00349492

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Soonchunhyang University Bucheon Hospital Bucheon-si, South Korea
  • Yeungnam University Hospital Daegu, South Korea
  • Daegu Catholic University Hospital Daegu, South Korea
  • Gyeongsang National University Hospital Jinju, South Korea
View all 14 locations
View Trial Details
Completed

A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.

NCT00600821

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +12 more
Locations
  • Pfizer Investigational Site Baton Rouge, Louisiana, United States
  • Pfizer Investigational Site Pittsfield, Massachusetts, United States
  • Pfizer Investigational Site Columbus, Mississippi, United States
  • Pfizer Investigational Site Corinth, Mississippi, United States
View all 44 locations
View Trial Details
Completed

Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer

NCT00147537

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Pfizer Investigational Site Tucson, Arizona, United States
  • Pfizer Investigational Site Tucson, Arizona, United States
  • Pfizer Investigational Site Tucson, Arizona, United States
  • Pfizer Investigational Site Greenbrae, California, United States
View all 31 locations
View Trial Details
Completed

A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone

NCT00457392

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Pfizer Investigational Site Florence, Alabama, United States
  • Pfizer Investigational Site Muscle Shoals, Alabama, United States
  • Pfizer Investigational Site Scottsdale, Arizona, United States
  • Pfizer Investigational Site Hot Springs, Arkansas, United States
View all 204 locations
View Trial Details

Related conditions